Reveal LINQ vs Irregular Rhythm Notification Feature (IRNF)
AI Verdict
Choose Reveal LINQ if…
Choose Reveal LINQ if a definitive, long-term diagnosis of infrequent or cryptogenic cardiac arrhythmias, such as atrial fibrillation or unexplained syncope, is critical. This implantable monitor provides continuous, highly accurate ECG recording for up to three years, leveraging AI to reduce false alerts and guide precise treatment decisions.
View Reveal LINQ →Choose Irregular Rhythm Notification Feature (IRNF) if…
Choose the Irregular Rhythm Notification Feature if you are an individual seeking a convenient, non-invasive method for proactive screening of potential irregular heart rhythms suggestive of AFib. This Apple Watch feature empowers users with notifications to facilitate early discussions with their physicians, serving as a valuable tool for initial awareness and self-monitoring.
View Irregular Rhythm Notification Feature (IRNF) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Reveal LINQ | Irregular Rhythm Notification Feature (IRNF) |
|---|---|---|
| Pricing | Unknown | Included with apple watch purchase |
| Deployment | The Reveal LINQ ICM is an implantable device placed just beneath the skin in the upper left side of the chest through a small incision. The system includes a MyCareLink™ Monitor, a bedside unit that collects data from the ICM and sends it to the doctor. The Reveal LINQ Mobile Manager app, used by healthcare professionals, is downloaded to an iPad or Android tablet and paired via Bluetooth to a Medtronic patient connector, which communicates with the ICMs. | Device-based (Apple Watch), integrated with the iPhone Health app. |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Irregular Rhythm Notification Feature (IRNF)Tool B (Apple IRNF) offers superior usability for the general consumer as it is integrated into a widely used wearable device (Apple Watch) and managed via a familiar mobile app. Tool A (Reveal LINQ) is an implantable medical device requiring a surgical procedure and clinician management, making it less accessible and user-friendly for the average person.
Clinical Value
Reveal LINQTool A (Reveal LINQ) provides continuous, long-term (up to three years) diagnostic-grade ECG monitoring, utilizing AI algorithms to accurately detect and diagnose various cardiac arrhythmias, including AFib, cryptogenic stroke, and unexplained syncope. Tool B (Apple IRNF) is a screening tool that identifies irregular rhythms suggestive of AFib, prompting users to consult a physician, but it is not a diagnostic device itself and cannot detect all instances of AFib.
Pricing & Value
Irregular Rhythm Notification Feature (IRNF)Tool B (Apple IRNF) is included with the purchase of an Apple Watch, offering proactive heart health insights at no additional cost beyond the device itself. Tool A (Reveal LINQ) is a specialized medical device with pricing typically negotiated with healthcare providers and covered by insurance, representing a significant cost for a targeted diagnostic intervention.
Enterprise Readiness
Reveal LINQTool A (Reveal LINQ) is a Medtronic product designed for integration into clinical workflows, with implied HIPAA compliance and dedicated data protection for patient health information, along with clinician-specific apps and a remote monitoring network (CareLinku2122). Tool B (Apple IRNF) is a consumer feature, and Apple explicitly states it does not offer a Business Associate Agreement (BAA), placing HIPAA compliance responsibility on covered entities for any shared data.
Innovation
TieBoth tools demonstrate significant innovation in their respective domains. Tool A (Reveal LINQ) is recognized as the world's smallest insertable cardiac monitor, offering continuous, long-term ECG monitoring with AI-powered accuracy for reduced false alerts. Tool B (Apple IRNF) innovates by bringing FDA-cleared, machine learning-based AFib screening to a mass-market consumer wearable, democratizing early detection and empowering users with health insights.
Support & Docs
Reveal LINQTool A (Reveal LINQ), as a Medtronic medical device, benefits from comprehensive professional support, including technical services, patient services, and extensive documentation tailored for healthcare professionals and patients with implanted devices. While Apple (Tool B) offers robust consumer support, Medtronic's specialized clinical and technical support for a complex implantable device provides a higher level of enterprise-relevant assistance and documentation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Reveal LINQ | Irregular Rhythm Notification Feature (IRNF) |
|---|---|---|
| Name | Reveal LINQ | Irregular Rhythm Notification Feature (IRNF) |
| Company | Medtronic | Apple |
| Primary Use/Detection | Accurately detect and diagnose cardiac arrhythmias, including atrial fibrillation, cryptogenic stroke, and unexplained syncope. | Screens for irregular heart rhythms suggestive of AFib, empowering users with notifications to facilitate discussions with their physicians. |
| Monitoring Duration | Continuous ECG monitoring for up to three years | Background heart rhythm checks during periods of stillness; not specified as continuous monitoring |
| Data Transmission/Management | Wireless data transmission to CareLinku2122 network via MyCareLinku2122 Patient Monitor; Reveal LINQu2122 Mobile Manager app for clinician device management. | Data saved securely to the Apple Health app on iPhone; ability for users to export and share health data with physicians. |
Videos
Demos, reviews, and walkthroughs featuring Reveal LINQ and Irregular Rhythm Notification Feature (IRNF).